Mark W. Donoghoe

1.6k total citations
53 papers, 1.1k citations indexed

About

Mark W. Donoghoe is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mark W. Donoghoe has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in Mark W. Donoghoe's work include Childhood Cancer Survivors' Quality of Life (16 papers), Family Support in Illness (8 papers) and Statistical Methods and Inference (7 papers). Mark W. Donoghoe is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (16 papers), Family Support in Illness (8 papers) and Statistical Methods and Inference (7 papers). Mark W. Donoghoe collaborates with scholars based in Australia, New Zealand and Finland. Mark W. Donoghoe's co-authors include Val Gebski, Anthony Keech, Ian C. Marschner, Rachel A Lart, Gerry V. Stimson, Timothy M. E. Davis, Alicia J. Jenkins, David Sullivan, Russell Scott and Rachel O’Connell and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mark W. Donoghoe

51 papers receiving 1.1k citations

Peers

Mark W. Donoghoe
Lingyi Lu United States
Catherine Copley‐Merriman United States
Alper Sevinç Türkiye
Elias Allara Italy
Joshua A. Halpern United States
Amy R. Bentley United States
Wendy Visscher United States
Martin Resnick United States
É. Huyghe France
Ahmet Alacacıoğlu Türkiye
Lingyi Lu United States
Mark W. Donoghoe
Citations per year, relative to Mark W. Donoghoe Mark W. Donoghoe (= 1×) peers Lingyi Lu

Countries citing papers authored by Mark W. Donoghoe

Since Specialization
Citations

This map shows the geographic impact of Mark W. Donoghoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Donoghoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Donoghoe more than expected).

Fields of papers citing papers by Mark W. Donoghoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Donoghoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Donoghoe. The network helps show where Mark W. Donoghoe may publish in the future.

Co-authorship network of co-authors of Mark W. Donoghoe

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Donoghoe. A scholar is included among the top collaborators of Mark W. Donoghoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Donoghoe. Mark W. Donoghoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wakefield, Claire E., Karen Johnston, Donna Drew, et al.. (2025). ‘Making Moves’: Protocol for a hybrid effectiveness-implementation pre-post trial of a co-designed online physical activity program for childhood cancer survivors. PubMed. 5. 100099–100099. 1 indexed citations
2.
Robertson, Eden G., et al.. (2024). The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer. Cancer Medicine. 13(12). e7339–e7339. 2 indexed citations
3.
Ezard, Nadine, Krista J. Siefried, Robert Ali, et al.. (2024). Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo‐controlled trial. Addiction. 120(7). 1345–1359. 2 indexed citations
4.
Wakefield, Claire E., Kate Hetherington, Eden G. Robertson, et al.. (2023). Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives. British Journal of Cancer. 129(10). 1634–1644. 10 indexed citations
5.
Fardell, Joanna E., Mark W. Donoghoe, Erica Jacobson, et al.. (2023). LGG-11. COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE ‘BENIGN TUMOR’ PERCEPTION. Neuro-Oncology. 25(Supplement_1). i57–i58. 1 indexed citations
6.
Hetherington, Kate, Eden G. Robertson, Mark W. Donoghoe, et al.. (2023). Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine. Cancer. 129(22). 3645–3655. 6 indexed citations
7.
Riepsamen, Angelique H., Mark W. Donoghoe, Inthrani R. Indran, et al.. (2022). Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clinical Endocrinology. 98(4). 567–577. 10 indexed citations
8.
Donoghoe, Mark W. & Ian C. Marschner. (2022). Parameter expansion for fitting regression models with non-negativity constraints. Communications in Statistics - Simulation and Computation. 53(9). 4412–4429.
9.
Wakefield, Claire E., Ursula M. Sansom‐Daly, Brittany C. McGill, et al.. (2021). Providing Psychological Support to Parents of Childhood Cancer Survivors: ‘Cascade’ Intervention Trial Results and Lessons for the Future. Cancers. 13(22). 5597–5597. 15 indexed citations
10.
Sansom‐Daly, Ursula M., Kate Hetherington, Brittany C. McGill, et al.. (2021). How Are Families Faring? Perceived Family Functioning Among Adolescent and Young Adult Cancer Survivors in Comparison to Their Peers. Journal of Adolescent and Young Adult Oncology. 10(6). 711–719. 3 indexed citations
11.
Riepsamen, Angelique H., Mark W. Donoghoe, Angela Baerwald, et al.. (2021). Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle. Fertility and Sterility. 116(2). 546–557. 8 indexed citations
12.
Barbour, Andrew P., Jaswinder S. Samra, Koroush S. Haghighi, et al.. (2020). The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer. Annals of Surgical Oncology. 27(7). 2506–2515. 18 indexed citations
13.
Nowak, Anna K., Peey‐Sei Kok, Ann Livingstone, et al.. (2017). P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In. Journal of Thoracic Oncology. 12(1). S1086–S1087. 1 indexed citations
14.
Donoghoe, Mark W. & Ian C. Marschner. (2015). Flexible Regression Models for Rate Differences, Risk Differences and Relative Risks. The International Journal of Biostatistics. 11(1). 91–108. 11 indexed citations
15.
16.
Darlow, Brian A., Simone Marschner, Mark W. Donoghoe, et al.. (2014). Randomized Controlled Trial of Oxygen Saturation Targets in Very Preterm Infants: Two Year Outcomes. The Journal of Pediatrics. 165(1). 30–35.e2. 59 indexed citations
17.
Keech, Anthony, Jaya Rajamani, James D. Best, et al.. (2011). Predictors of peripheral neuropathy and effects of fenofibrate among 9,795 subjects with type 2 diabetes: the fenofibrate intervention and event lowering in diabetes (FIELD) study. Diabetologia. 54.
18.
Scott, Russell, Mark W. Donoghoe, Gerald F. Watts, et al.. (2011). Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial. Cardiovascular Diabetology. 10(1). 102–102. 44 indexed citations
19.
Rajamani, Kushwin, Mark W. Donoghoe, Liping Li, et al.. (2010). Abstract 18987: Fenofibrate Reduces Peripheral Neuropathy in Type 2 Diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Circulation. 122. 2 indexed citations
20.
Keech, Anthony, Paul Drury, Timothy M. E. Davis, et al.. (2009). Protection against nephropathy with fenofibrate in type 2 diabetes mellitus: the FIELD study. Circulation. 120. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingyi Lu Breakdown of academic impact, for papers by Catherine Copley‐Merriman Breakdown of academic impact, for papers by Alper Sevinç Breakdown of academic impact, for papers by Elias Allara Breakdown of academic impact, for papers by Joshua A. Halpern Breakdown of academic impact, for papers by Amy R. Bentley Breakdown of academic impact, for papers by Wendy Visscher Breakdown of academic impact, for papers by Martin Resnick Breakdown of academic impact, for papers by É. Huyghe Breakdown of academic impact, for papers by Ahmet Alacacıoğlu
Rankless by CCL
2026